Laser or ultrasound: which zaps heel pain best?
NCT ID NCT07462169
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested two device-based treatments—high-intensity laser and high-power ultrasound—against standard care for plantar fasciitis. 51 adults with heel pain for at least a month received one of the therapies three times a week for a month. Researchers measured pain levels and pressure pain threshold to see which approach works better.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- high-intensity laser therapy and high-power pain threshold ultrasound
- What this could lead to
- If one device works better, it could offer a more effective, non-invasive option for reducing heel pain and improving daily movement.
- What could go wrong
- This is a small, completed trial with only 51 participants, so results may not apply to everyone. Both treatments are compared to standard care, and neither is a cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
51 people
The number who actually took part.
- Started
-
Mar 2026
- Finished
-
Jun 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
30 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. The patient age ranged from 30 to 60 years. 2. Plantar heel pain lasting for at least one month, mainly during the first few steps upon rising in the morning, which worsens with increased weight-bearing activity through the day. 3. Tenderness at the insertion site of the plantar fascia on the calcaneus. 4. Body mass index (MBI) \<30 kg/m2 Exclusion Criteria: 1. Medical red flag history (such as tumor, fracture, heterotrophic ossification, and acute inflammatory disease in the ankle-foot area. 2. If the patient has history of recent trauma or foot surgery. 3. Wounds, infections in the treatment area. 4. Subjects with referred pain from sciatica and other neurological disorders. 5. History of corticosteroid injection in the last 6 months.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Plantar fasciitis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Physical Therapy Benha National University.
Cairo, Egypt
-
Outpatient clinic of Faculty of Physical Therapy Benha National University.
Banhā, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heel pain Face-Off: nerve zapping vs. Blood-Based injection vs. both
- Tape or stretch? trial tests two ways to ease heel pain
- Nature trails may be a new prescription for foot pain
- Can 3D-Printed insoles beat milled ones for heel pain?
- Blood marker may shed light on stubborn heel pain
- Can a CBD cream soothe heel pain fast?